Department of Pharmacology, Institute of Oriental Medicine, College of Oriental Medicine, School of Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea.
Exp Biol Med (Maywood). 2011 Jan;236(1):99-106. doi: 10.1258/ebm.2010.010252.
Allergy is characterized by an overreaction of the immune system. Perilla frutescens leaf extract has been reported to exhibit antiallergic inflammatory activity. To investigate precisely the effect and mechanism of 30% ethanol extract powder of P. frutescens var. acuta Kudo (EPPF) and rosmarinic acid (RA), a component of EPPF in allergic rhinitis and rhinoconjunctivitis, the antiallergic effects of EPPF and RA were analyzed using in vivo and in vitro models. Cytokine production was analyzed by means of an enzyme-linked immunosorbent assay. Cytokine expression was analyzed via reverse transcription-polymerase chain reaction and Western blotting. Transcription factor and caspase-1 activity were analyzed by a luciferase assay and caspase-1 assay, respectively. The number of nasal, ear and eye rubs after an ovalbumin (OVA) challenge in OVA-sensitized mice was significantly higher than that in OVA-unsensitized mice. Increased number of rubs was inhibited by administration of EPPF or RA. Increased levels of IgE in the serum, spleen and nasal mucosa of OVA-sensitized mice were reduced by EPPF or RA administration. The histamine level was also reduced by EPPF or RA administration in the serum of OVA-sensitized mice. Protein levels and mRNA expressions of interleukin (IL)-1β, IL-6 and tumor necrosis factor-α were inhibited by EPPF or RA administration in the nasal mucosa tissue or spleen of OVA-sensitized mice. In EPPF or RA-administered mice, the mast cell and eosinophil infiltration increase as caused by OVA-sensitization was decreased. In addition, EPPF or RA inhibited both cyclooxygenase-2 protein expression and caspase-1 activity in the same nasal mucosa tissue. In activated human mast cells, nuclear factor-kappa B (NF-κB)/Rel A and caspase-1 activation increased, whereas NF-κB/Rel A and caspase-1 activation was inhibited after a treatment of EPPF or RA. These results indicate that EPPF and RA ameliorate allergic inflammatory reactions such as allergic rhinitis and allergic rhinoconjunctivitis.
过敏是免疫系统过度反应的特征。据报道,紫苏叶提取物具有抗过敏性炎症活性。为了准确研究紫苏 30%乙醇提取物粉末(EPPF)和迷迭香酸(RA),即 EPPF 的一种成分,在过敏性鼻炎和过敏性鼻结膜炎中的作用和机制,我们采用体内和体外模型分析了 EPPF 和 RA 的抗过敏作用。通过酶联免疫吸附试验分析细胞因子的产生。通过逆转录聚合酶链反应和 Western blot 分析细胞因子的表达。通过荧光素酶测定法和半胱氨酸天冬氨酸蛋白酶-1(caspase-1)测定法分析转录因子和 caspase-1 活性。卵清蛋白(OVA)致敏小鼠在 OVA 攻击后的鼻、耳和眼摩擦次数明显高于 OVA 未致敏小鼠。EPPF 或 RA 给药可抑制摩擦次数的增加。EPPF 或 RA 给药可降低 OVA 致敏小鼠血清、脾脏和鼻黏膜中 IgE 的水平。EPPF 或 RA 给药还可降低 OVA 致敏小鼠血清中的组胺水平。EPPF 或 RA 给药可抑制 OVA 致敏小鼠鼻黏膜组织或脾脏中白细胞介素(IL)-1β、IL-6 和肿瘤坏死因子-α的蛋白水平和 mRNA 表达。在 EPPF 或 RA 给药的小鼠中,OVA 致敏引起的肥大细胞和嗜酸性粒细胞浸润增加减少。此外,EPPF 或 RA 抑制了同一鼻黏膜组织中环氧化酶-2 蛋白表达和半胱氨酸天冬氨酸蛋白酶-1 活性。在活化的人肥大细胞中,EPPF 或 RA 处理后核因子-κB(NF-κB)/Rel A 和半胱氨酸天冬氨酸蛋白酶-1 的激活增加。这些结果表明,EPPF 和 RA 可改善过敏性炎症反应,如过敏性鼻炎和过敏性鼻结膜炎。